Hospital morbidity and mortality due to malignant lip, oral cavity and pharynx neoplasms in public hospitals in Bahia

• Autor(a) principal: Santana, Rodolfo dos Santos
• Data de Publicação: 2023
• Outros Autores: Queiroz, Letícia Silva das Virgens, Santos, Aline Barbosa dos
• Tipo de documento: Artigo
• Idioma: por
• Título da fonte: Revista Baiana de Saúde Pública (Online)
• Texto Completo: https://rbsp.sesab.ba.gov.br/index.php/rbsp/article/view/3900
• topic: Neoplasias bucais; Indicadores de morbimortabilidade; Epidemiologia; Neoplasias bucales; Indicadores de morbimortabilidad; Epidemiología; Mouth neoplasms; Indicators of morbidity and mortality; Epidemiology

Mouth and pharyngeal cancers are among the ten most common types of cancer worldwide, especially in developing countries. Few studies have evaluated the epidemiological and clinicopathological characteristics of mouth cancer in Brazil, with most conducted in southeastern states, reflecting the scarcity of information regarding this type of neoplasm in northeastern Brazil. Thus, this descriptive and exploratory study evaluates the epidemiological aspects of morbidity and mortality due to malignant lip, mouth, and pharynx neoplasms in patients treated at public hospitals in Bahia from 2018 to 2022. Secondary data was obtained for hospital mortality and morbidity from the Brazilian Unified Health System (DATASUS) database. A total of 6,527 hospitalizations due to malignant neoplasms were recorded, with the Eastern, Central-Eastern, and Southwest regions accounting, respectively, for 25.5%, 21.6%, and 13.3% of hospitalized users. There were 880 recorded deaths. The highest morbidity and mortality occurred among black and mixed-race men aged 50 to 69 years.